Spore.Bio raised $23M in a Series A round led by Singular to enhance microbiology testing with machine learning.
Feb 20, 2025•8 months ago
Amount Raised
$23 Million
Round Type
series a
ParisManufacturingInvestors
Famille CNo Label VenturesLocal GlobeLord David PriorStation F1st Kind VenturesPoint 72 VenturesSingular
Description
Spore.Bio, a Paris-based deeptech startup, has secured $23 million in a Series A funding round. The company aims to revolutionize microbiology testing in the food industry to prevent contamination crises and has already garnered significant customer interest.
Funding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech